25 XP   0   0   10

Vera Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Vera Therapeutics Inc together

PenkeI guess you are interested in Vera Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vera Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Vera Therapeutics Inc

I send you an email if I find something interesting about Vera Therapeutics Inc.

Quick analysis of Vera Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Vera Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.79
Expected worth in 1 year
$3.19
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$0.40
Return On Investment
3.1%

For what price can you sell your share?

Current Price per Share
$13.00
Expected price per share
$8.64 - $16.52
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Vera Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$13.00

2. Growth of Vera Therapeutics Inc (5 min.)




Is Vera Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$123.7m$107.8m$16.9m13.6%

How much money is Vera Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$25.6m-$18.1m-$7.4m-29.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Vera Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#364 / 1072

Most Revenue
#824 / 1072

Most Profit
#820 / 1072

Most Efficient
#257 / 1072
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Vera Therapeutics Inc? (5 min.)

Welcome investor! Vera Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Vera Therapeutics Inc.

What can you expect buying and holding a share of Vera Therapeutics Inc?

First you should know what it really means to hold a share of Vera Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Vera Therapeutics Inc is $13.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vera Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vera Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.79. Based on the TTM, the Book Value Change Per Share is $0.10 per quarter. Based on the YOY, the Book Value Change Per Share is $0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vera Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.45-3.5%0.765.9%-0.41-3.2%0.000.0%0.000.0%
Usd Book Value Change Per Share-0.38-2.9%0.100.8%0.110.9%0.231.8%0.231.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.38-2.9%0.100.8%0.110.9%0.231.8%0.231.8%
Usd Price Per Share13.71-14.22-21.28-14.38-14.38-
Price to Earnings Ratio-7.56--3.01--13.13--10.08--10.08-
Price-to-Total Gains Ratio-35.86--25.69--41.25--37.97--37.97-
Price to Book Ratio4.92-5.83-9.66-6.45-6.45-
Price-to-Total Gains Ratio-35.86--25.69--41.25--37.97--37.97-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share13
Number of shares76
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.100.23
Usd Total Gains Per Share0.100.23
Gains per Quarter (76 shares)7.6617.66
Gains per Year (76 shares)30.6370.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10312107161
2061520141132
3092830212203
401231140283274
501531450353345
601841760424416
702142070494487
802452380565558
902762690636629
1003063000706700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%2.010.00.016.7%2.010.00.016.7%2.010.00.016.7%2.010.00.016.7%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%3.09.00.025.0%3.09.00.025.0%3.09.00.025.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.012.00.0%0.00.012.00.0%0.00.012.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%3.09.00.025.0%3.09.00.025.0%3.09.00.025.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Vera Therapeutics Inc

About Vera Therapeutics Inc

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Fundamental data was last updated by Penke on 2023-11-12 04:29:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Vera Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vera Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vera Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--168.3%+168.3%
TTM--201.8%+201.8%
YOY--288.3%+288.3%
5Y--475.5%+475.5%
10Y--632.1%+632.1%
1.1.2. Return on Assets

Shows how efficient Vera Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • -11.4% Return on Assets means that Vera Therapeutics Inc generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vera Therapeutics Inc:

  • The MRQ is -11.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.4%TTM-15.2%+3.7%
TTM-15.2%YOY-14.7%-0.5%
TTM-15.2%5Y-18.2%+3.1%
5Y-18.2%10Y-18.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.4%-12.4%+1.0%
TTM-15.2%-11.8%-3.4%
YOY-14.7%-11.0%-3.7%
5Y-18.2%-13.6%-4.6%
10Y-18.2%-15.1%-3.1%
1.1.3. Return on Equity

Shows how efficient Vera Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • -16.3% Return on Equity means Vera Therapeutics Inc generated $-0.16 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vera Therapeutics Inc:

  • The MRQ is -16.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -22.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.3%TTM-22.9%+6.7%
TTM-22.9%YOY-18.0%-5.0%
TTM-22.9%5Y-14.7%-8.2%
5Y-14.7%10Y-14.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.3%-14.9%-1.4%
TTM-22.9%-15.0%-7.9%
YOY-18.0%-13.2%-4.8%
5Y-14.7%-18.7%+4.0%
10Y-14.7%-19.5%+4.8%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Vera Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vera Therapeutics Inc is operating .

  • Measures how much profit Vera Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vera Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--288.2%+288.2%
TTM--293.7%+293.7%
YOY--304.1%+304.1%
5Y--455.8%+455.8%
10Y--568.9%+568.9%
1.2.2. Operating Ratio

Measures how efficient Vera Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.948-2.948
TTM-3.225-3.225
YOY-3.885-3.885
5Y-5.988-5.988
10Y-7.846-7.846
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Vera Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vera Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.97 means the company has $6.97 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 6.970. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.918. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.970TTM6.918+0.052
TTM6.918YOY8.680-1.762
TTM6.9185Y12.192-5.274
5Y12.19210Y12.1920.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.9704.061+2.909
TTM6.9184.483+2.435
YOY8.6805.670+3.010
5Y12.1926.256+5.936
10Y12.1926.629+5.563
1.3.2. Quick Ratio

Measures if Vera Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 11.88 means the company can pay off $11.88 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 11.878. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 10.571. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.878TTM10.571+1.306
TTM10.571YOY11.205-0.633
TTM10.5715Y14.052-3.481
5Y14.05210Y14.0520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.8783.653+8.225
TTM10.5714.161+6.410
YOY11.2055.503+5.702
5Y14.0526.035+8.017
10Y14.0526.369+7.683
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Vera Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vera Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vera Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.30 means that Vera Therapeutics Inc assets are financed with 29.6% credit (debt) and the remaining percentage (100% - 29.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 0.296. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.310. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.296TTM0.310-0.014
TTM0.310YOY0.183+0.126
TTM0.3105Y0.627-0.318
5Y0.62710Y0.6270.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2960.330-0.034
TTM0.3100.326-0.016
YOY0.1830.260-0.077
5Y0.6270.371+0.256
10Y0.6270.387+0.240
1.4.2. Debt to Equity Ratio

Measures if Vera Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 42.0% means that company has $0.42 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 0.420. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.462. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.420TTM0.462-0.042
TTM0.462YOY0.224+0.237
TTM0.4625Y0.239+0.222
5Y0.23910Y0.2390.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4200.377+0.043
TTM0.4620.388+0.074
YOY0.2240.306-0.082
5Y0.2390.432-0.193
10Y0.2390.469-0.230
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Vera Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Vera Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -7.56 means the investor is paying $-7.56 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vera Therapeutics Inc:

  • The EOD is -7.172. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.563. Based on the earnings, the company is expensive. -2
  • The TTM is -3.013. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.172MRQ-7.563+0.392
MRQ-7.563TTM-3.013-4.550
TTM-3.013YOY-13.131+10.118
TTM-3.0135Y-10.083+7.070
5Y-10.08310Y-10.0830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.172-1.847-5.325
MRQ-7.563-2.497-5.066
TTM-3.013-2.736-0.277
YOY-13.131-4.719-8.412
5Y-10.083-6.398-3.685
10Y-10.083-6.639-3.444
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vera Therapeutics Inc:

  • The EOD is 49.326. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 52.020. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 7.154. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD49.326MRQ52.020-2.694
MRQ52.020TTM7.154+44.866
TTM7.154YOY-23.904+31.058
TTM7.1545Y-10.102+17.256
5Y-10.10210Y-10.1020.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD49.326-2.053+51.379
MRQ52.020-2.722+54.742
TTM7.154-3.420+10.574
YOY-23.904-6.608-17.296
5Y-10.102-8.240-1.862
10Y-10.102-8.875-1.227
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vera Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.92 means the investor is paying $4.92 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vera Therapeutics Inc:

  • The EOD is 4.662. Based on the equity, the company is fair priced.
  • The MRQ is 4.917. Based on the equity, the company is fair priced.
  • The TTM is 5.827. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.662MRQ4.917-0.255
MRQ4.917TTM5.827-0.911
TTM5.827YOY9.665-3.837
TTM5.8275Y6.445-0.618
5Y6.44510Y6.4450.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.6621.648+3.014
MRQ4.9171.901+3.016
TTM5.8272.114+3.713
YOY9.6653.217+6.448
5Y6.4453.614+2.831
10Y6.4454.101+2.344
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vera Therapeutics Inc.

3.1. Institutions holding Vera Therapeutics Inc

Institutions are holding 97.092% of the shares of Vera Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-06-30FMR Inc14.74680.00886535560-5056958-43.6226
2023-06-30COMMODORE CAPITAL LP12.29749.83025450000262597192.9867
2023-06-30Sofinnova Ventures7.82333.6448346715600
2023-06-30Kynam Capital Management, LP6.76926.62253000000-372428-11.0433
2023-06-30The Carlyle Group Inc5.45331.38092416837-543394-18.3565
2023-06-30BlackRock Inc4.89670.001217013475986453.8807
2023-06-30Orbimed Advisors, LLC3.9640.5109175680039440028.9489
2023-06-30Woodline Partners LP3.9570.333617536909720.0555
2023-06-30Eversept Partners, LLC3.92832.89221740951-47578-2.6602
2023-06-30Vanguard Group Inc3.24980.00061440265454143.2558
2023-06-30International Biotechnology Trust PLC2.20054.7618975227-27030-2.6969
2023-06-30Morgan Stanley - Brokerage Accounts2.18430.00159680459273772280.3605
2023-06-30Geode Capital Management, LLC1.46820.001265069217064735.5481
2023-06-30State Street Corporation1.30090.000557654927240289.5626
2023-06-30Sectoral Asset Management Inc0.79350.941351646-248654-41.4216
2023-06-30Millennium Management LLC0.75290.0026333689-1553662-82.3197
2023-06-30Alphabet Inc0.68050.260130158000
2023-06-30Goldman Sachs Group Inc0.64420.00092854932854930
2023-06-30Northern Trust Corp0.62610.00092774638407843.477
2023-06-30Amvescap Plc.0.61960.00122746102746100
Total 78.356531.197234726387-2008476-5.8%

3.2. Funds holding Vera Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-10-31SPDR® S&P Biotech ETF2.58550.2315114586940590.3555
2023-09-30Fidelity® Select Health Care2.25640.18100000000
2023-07-31Biotech Growth Ord2.22444.42298580000
2023-09-30Fidelity Growth Compy Commingled Pl O2.17830.022296537149230.5126
2023-09-30Vanguard Total Stock Mkt Idx Inv1.88540.000983557400
2023-03-31Vanguard Instl Ttl Stck Mkt Idx Tr1.88540.0005835574425789103.9055
2023-09-30Fidelity® Growth Company1.78720.0232792051-4923-0.6177
2023-10-31iShares Russell 2000 ETF1.74160.016877186377141.0095
2023-09-30Fidelity Advisor® Health Care I1.57950.18770000000
2023-09-30Xtrackers S&P 500 Swap ETF 1C1.39460.119861804700
2023-09-30Vanguard Institutional Extnd Mkt Idx Tr1.14370.008150687710624926.5206
2023-08-31Fidelity® Small Cap Growth0.91470.135940540000
2023-09-30Fidelity® Select Biotechnology0.88180.1242390790-193800-33.1514
2023-08-31Fidelity® Small Cap Index0.70070.024931054085272.8234
2023-09-30Fidelity® Growth Company K60.60710.023126906100
2023-09-30UTM IM GBP AXA Framlington Biotech0.5860.725972300
2023-10-31Invesco Dorsey Wright Healthcare MomtETF0.49151.979821781900
2023-09-30State St Russell Sm/Mid Cp® Indx NL Cl C0.4390.00791945541820010.3202
2023-09-30Fidelity® Extended Market Index0.41580.00811842933192420.9518
2023-10-31iShares Russell 2000 Value ETF0.36160.017160273-104-0.0648
Total 26.06028.232911549479+408558+3.5%

3.3. Insider Transactions

Insiders are holding 7.349% of the shares of Vera Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-08-21Marshall FordyceSELL521016.66
2023-08-21Celia LinSELL149016.65
2023-06-23Sean GrantBUY500016.6
2023-06-20Commodore Capital LpBUY44821715.17
2023-03-30Beth C SeidenbergBUY23007.24
2023-03-27Beth C SeidenbergBUY16337.24
2023-03-24Beth C SeidenbergBUY18337.24
2023-03-20Beth C SeidenbergBUY152527.21
2023-03-17Beth C SeidenbergBUY740457.12
2023-03-15Beth C SeidenbergBUY328447.12
2023-03-10Beth C SeidenbergBUY480037.16
2023-03-03Beth C SeidenbergBUY10007.25
2023-03-01Beth C SeidenbergBUY1007.25
2023-02-23Beth C SeidenbergBUY2007.24
2023-02-13Beth C SeidenbergBUY100727.2
2023-02-08Beth C SeidenbergBUY453577.22
2023-02-06Patrick G EnrightBUY17142857
2023-02-06Sofinnova Venture Partners X,BUY2857147
2023-02-03Beth C SeidenbergBUY461637.24
2022-12-16Joanne CurleySELL221219.49
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Vera Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.3820.101-479%0.114-435%0.232-265%0.232-265%
Book Value Per Share--2.7882.813-1%2.433+15%1.739+60%1.739+60%
Current Ratio--6.9706.918+1%8.680-20%12.192-43%12.192-43%
Debt To Asset Ratio--0.2960.310-4%0.183+61%0.627-53%0.627-53%
Debt To Equity Ratio--0.4200.462-9%0.224+87%0.239+75%0.239+75%
Dividend Per Share----0%-0%-0%-0%
Eps---0.4530.764-159%-0.414-9%0.004-11477%0.004-11477%
Free Cash Flow Per Share--0.066-0.352+633%-0.299+553%-0.301+556%-0.301+556%
Free Cash Flow To Equity Per Share--0.0660.377-83%0.187-65%0.438-85%0.438-85%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap576139200.000-6%608222474.490630251154.623-3%943206348.000-36%637534686.208-5%637534686.208-5%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio4.662-5%4.9175.827-16%9.665-49%6.445-24%6.445-24%
Pe Ratio-7.172+5%-7.563-3.013-60%-13.131+74%-10.083+33%-10.083+33%
Price Per Share13.000-5%13.71014.218-4%21.283-36%14.384-5%14.384-5%
Price To Free Cash Flow Ratio49.326-5%52.0207.154+627%-23.904+146%-10.102+119%-10.102+119%
Price To Total Gains Ratio-34.007+5%-35.865-25.691-28%-41.250+15%-37.974+6%-37.974+6%
Quick Ratio--11.87810.571+12%11.205+6%14.052-15%14.052-15%
Return On Assets---0.114-0.152+32%-0.147+28%-0.182+59%-0.182+59%
Return On Equity---0.163-0.229+41%-0.180+11%-0.147-10%-0.147-10%
Total Gains Per Share---0.3820.101-479%0.114-435%0.232-265%0.232-265%
Usd Book Value--123707000.000124711750.000-1%107809750.000+15%77087833.333+60%77087833.333+60%
Usd Book Value Change Per Share---0.3820.101-479%0.114-435%0.232-265%0.232-265%
Usd Book Value Per Share--2.7882.813-1%2.433+15%1.739+60%1.739+60%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.4530.764-159%-0.414-9%0.004-11477%0.004-11477%
Usd Free Cash Flow--2923000.000-15577250.000+633%-13233500.000+553%-13324583.333+556%-13324583.333+556%
Usd Free Cash Flow Per Share--0.066-0.352+633%-0.299+553%-0.301+556%-0.301+556%
Usd Free Cash Flow To Equity Per Share--0.0660.377-83%0.187-65%0.438-85%0.438-85%
Usd Market Cap576139200.000-6%608222474.490630251154.623-3%943206348.000-36%637534686.208-5%637534686.208-5%
Usd Price Per Share13.000-5%13.71014.218-4%21.283-36%14.384-5%14.384-5%
Usd Profit---20104000.000-25614750.000+27%-18189750.000-10%-19487916.667-3%-19487916.667-3%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.3820.101-479%0.114-435%0.232-265%0.232-265%
 EOD+4 -4MRQTTM+13 -16YOY+12 -175Y+11 -1810Y+11 -18

4.2. Fundamental Score

Let's check the fundamental score of Vera Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.172
Price to Book Ratio (EOD)Between0-14.662
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than111.878
Current Ratio (MRQ)Greater than16.970
Debt to Asset Ratio (MRQ)Less than10.296
Debt to Equity Ratio (MRQ)Less than10.420
Return on Equity (MRQ)Greater than0.15-0.163
Return on Assets (MRQ)Greater than0.05-0.114
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Vera Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.122
Ma 20Greater thanMa 5012.235
Ma 50Greater thanMa 10012.236
Ma 100Greater thanMa 20014.945
OpenGreater thanClose12.800
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Net Debt  -18,3406,167-12,173-94,530-106,703102,907-3,7965,8772,081



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets175,618
Total Liabilities51,911
Total Stockholder Equity123,707
 As reported
Total Liabilities 51,911
Total Stockholder Equity+ 123,707
Total Assets = 175,618

Assets

Total Assets175,618
Total Current Assets171,620
Long-term Assets171,620
Total Current Assets
Cash And Cash Equivalents 27,441
Short-term Investments 132,498
Other Current Assets 11,681
Total Current Assets  (as reported)171,620
Total Current Assets  (calculated)171,620
+/-0
Long-term Assets
Property Plant Equipment 3,515
Long-term Assets Other 470
Long-term Assets  (as reported)3,998
Long-term Assets  (calculated)3,985
+/- 13

Liabilities & Shareholders' Equity

Total Current Liabilities24,621
Long-term Liabilities27,290
Total Stockholder Equity123,707
Total Current Liabilities
Short-term Debt 2,518
Accounts payable 12,300
Other Current Liabilities 9,803
Total Current Liabilities  (as reported)24,621
Total Current Liabilities  (calculated)24,621
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)27,290
Long-term Liabilities  (calculated)0
+/- 27,290
Total Stockholder Equity
Common Stock44
Retained Earnings -283,447
Accumulated Other Comprehensive Income -75
Other Stockholders Equity 407,185
Total Stockholder Equity (as reported)123,707
Total Stockholder Equity (calculated)123,707
+/-0
Other
Cash and Short Term Investments 159,939
Common Stock Shares Outstanding 44,363
Liabilities and Stockholders Equity 175,618
Net Debt 2,081
Net Working Capital 146,999
Short Long Term Debt Total 29,522



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
54,554
51,825
97,647
91,167
83,748
164,974
148,782
131,370
131,435
209,604
195,178
175,618
175,618195,178209,604131,435131,370148,782164,97483,74891,16797,64751,82554,554000
   > Total Current Assets 
0
0
0
54,261
51,532
95,876
89,760
82,537
157,743
142,338
124,982
125,698
204,449
190,614
171,620
171,620190,614204,449125,698124,982142,338157,74382,53789,76095,87651,53254,261000
       Cash And Cash Equivalents 
0
0
0
53,654
49,505
91,625
86,191
79,674
111,506
50,427
30,475
43,459
137,385
33,889
27,441
27,44133,889137,38543,45930,47550,427111,50679,67486,19191,62549,50553,654000
       Short-term Investments 
0
0
0
0
0
1,478
0
867
39,432
81,501
83,945
71,194
59,768
147,132
132,498
132,498147,13259,76871,19483,94581,50139,43286701,47800000
       Net Receivables 
0
0
0
52
0
0
0
0
0
0
0
0
0
0
0
0000000000052000
       Other Current Assets 
0
0
0
83
81
475
786
2,863
759
776
792
823
7,296
1,399
11,681
11,6811,3997,2968237927767592,8637864758183000
   > Long-term Assets 
0
0
0
293
293
1,771
1,407
1,211
7,231
6,444
6,388
5,737
5,155
4,564
3,998
3,9984,5645,1555,7376,3886,4447,2311,2111,4071,771293293000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
6,291
5,745
5,824
5,224
4,594
4,070
3,515
3,5154,0704,5945,2245,8245,7456,29100000000
       Long Term Investments 
0
0
0
0
0
1,478
1,114
867
580
324
122
58
57
29
0
02957581223245808671,1141,47800000
       Other Assets 
0
0
0
293
293
293
293
344
360
375
498
0
0
0
0
0000498375360344293293293293000
> Total Liabilities 
0
0
0
143,902
145,141
5,492
5,690
14,156
30,549
27,278
25,652
54,527
51,895
54,655
51,911
51,91154,65551,89554,52725,65227,27830,54914,1565,6905,492145,141143,902000
   > Total Current Liabilities 
0
0
0
2,406
3,753
3,771
4,042
7,690
19,969
17,279
15,920
25,600
23,529
26,835
24,621
24,62126,83523,52925,60015,92017,27919,9697,6904,0423,7713,7532,406000
       Short-term Debt 
0
0
0
2
0
0
0
0
2,490
2,450
2,689
2,645
2,602
2,560
2,518
2,5182,5602,6022,6452,6892,4502,49000002000
       Accounts payable 
0
0
0
909
1,440
1,723
964
1,385
7,328
7,084
7,012
11,991
5,326
13,280
12,300
12,30013,2805,32611,9917,0127,0847,3281,3859641,7231,440909000
       Other Current Liabilities 
0
0
0
962
2,313
2,048
3,078
6,305
10,151
7,745
6,219
10,964
15,601
10,995
9,803
9,80310,99515,60110,9646,2197,74510,1516,3053,0782,0482,313962000
   > Long-term Liabilities 
0
0
0
141,496
141,388
1,721
1,648
6,466
10,580
9,999
9,732
28,927
28,366
27,820
27,290
27,29027,82028,36628,9279,7329,99910,5806,4661,6481,721141,388141,496000
       Long term Debt Total 
0
0
0
0
0
0
0
4,923
4,937
4,952
4,966
24,810
24,886
0
0
0024,88624,8104,9664,9524,9374,9230000000
       Warrants
0
0
0
0
139,576
139,576
0
0
0
0
0
0
0
0
0
000000000139,576139,5760000
       Other Liabilities 
0
0
0
1,920
1,812
1,721
1,648
1,543
286
286
286
0
0
0
0
00002862862861,5431,6481,7211,8121,920000
> Total Stockholder Equity
0
0
0
-89,348
-93,316
92,155
85,477
69,592
134,425
121,504
105,718
76,908
157,709
140,523
123,707
123,707140,523157,70976,908105,718121,504134,42569,59285,47792,155-93,316-89,348000
   Common Stock
0
0
0
0
0
21
21
21
27
27
28
28
44
44
44
4444442828272721212100000
   Retained Earnings Total Equity00-243,181-213,112-180,673-155,994-141,141-124,056-107,209-96,161-96,1610000
   Accumulated Other Comprehensive Income -75-142-4-224-279-152-120-91,167-97,64700000
   Capital Surplus 
0
0
0
0
2,845
2,845
192,665
193,627
275,551
277,623
286,642
290,216
400,850
0
0
00400,850290,216286,642277,623275,551193,627192,6652,8452,8450000
   Treasury Stock000000000000000
   Other Stockholders Equity 
0
0
0
2,099
-136,731
191,732
192,665
193,627
275,551
277,623
286,642
290,216
400,850
403,964
407,185
407,185403,964400,850290,216286,642277,623275,551193,627192,665191,732-136,7312,099000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-90,903
Operating Income-90,903-90,903
 
Operating Expense (+$)
Research Development68,993
Selling General Administrative21,910
Selling And Marketing Expenses0
Operating Expense90,90390,903
 
Net Interest Income (+$)
Interest Income1,750
Interest Expense-992
Other Finance Cost-0
Net Interest Income758
 
Pretax Income (+$)
Operating Income-90,903
Net Interest Income758
Other Non-Operating Income Expenses-2,840
Income Before Tax (EBT)-89,055-92,751
EBIT - interestExpense = -91,049
-89,055
-88,064
Interest Expense992
Earnings Before Interest and Taxes (EBIT)-90,057-88,063
Earnings Before Interest and Taxes (EBITDA)-90,903
 
After tax Income (+$)
Income Before Tax-89,055
Tax Provision-1
Net Income From Continuing Ops89,056-89,056
Net Income-89,056
Net Income Applicable To Common Shares89,056
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses90,903
Total Other Income/Expenses Net1,8482,082
 

Technical Analysis of Vera Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vera Therapeutics Inc. The general trend of Vera Therapeutics Inc is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vera Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vera Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 14.27 < 15.38 < 16.52.

The bearish price targets are: 9.68 > 9.24 > 8.64.

Tweet this
Vera Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vera Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vera Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vera Therapeutics Inc. The current macd is 0.4268501.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vera Therapeutics Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Vera Therapeutics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Vera Therapeutics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Vera Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartVera Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vera Therapeutics Inc. The current adx is 29.05.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Vera Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Vera Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vera Therapeutics Inc. The current sar is 14.23.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Vera Therapeutics Inc Daily Parabolic SAR Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vera Therapeutics Inc. The current rsi is 55.12. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Vera Therapeutics Inc Daily Relative Strength Index (RSI) ChartVera Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vera Therapeutics Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vera Therapeutics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Vera Therapeutics Inc Daily Stochastic Oscillator ChartVera Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vera Therapeutics Inc. The current cci is 38.66.

Vera Therapeutics Inc Daily Commodity Channel Index (CCI) ChartVera Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vera Therapeutics Inc. The current cmo is 11.70.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Vera Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartVera Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vera Therapeutics Inc. The current willr is -33.68700265.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vera Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vera Therapeutics Inc Daily Williams %R ChartVera Therapeutics Inc Daily Williams %R Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vera Therapeutics Inc.

Vera Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vera Therapeutics Inc. The current atr is 0.97032047.

Vera Therapeutics Inc Daily Average True Range (ATR) ChartVera Therapeutics Inc Daily Average True Range (ATR) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vera Therapeutics Inc. The current obv is 5,806,113.

Vera Therapeutics Inc Daily On-Balance Volume (OBV) ChartVera Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vera Therapeutics Inc. The current mfi is 65.21.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Vera Therapeutics Inc Daily Money Flow Index (MFI) ChartVera Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vera Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-07-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-07-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-07-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-07-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-07-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-08-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-08-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-08-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-08-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-08-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-08-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-08-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-08-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-08-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-08-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-08-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-09-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-09-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-09-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-09-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-09-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-09-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-09-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-09-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-25STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-09-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-09-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-10-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-10-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-10-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-10-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-10-20STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-10-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Vera Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vera Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.122
Ma 20Greater thanMa 5012.235
Ma 50Greater thanMa 10012.236
Ma 100Greater thanMa 20014.945
OpenGreater thanClose12.800
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Vera Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Vera Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vera Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vera Therapeutics Inc

I send you an email if I find something interesting about Vera Therapeutics Inc.


Comments

How you think about this?

Leave a comment
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Stay informed about Vera Therapeutics Inc.

Receive notifications about Vera Therapeutics Inc in your mailbox!